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Abstract
While the methylation of DNA in 5′ promoters suppresses gene expression, the role of DNA 
methylation in gene bodies is unclear1–5. In mammals, tissue- and cell type-specific methylation is 
present in a small percentage of 5′ CpG island (CGI) promoters, while a far greater proportion 
occurs across gene bodies, coinciding with highly conserved sequences5–10. Tissue-specific 
intragenic methylation might reduce,3 or, paradoxically, enhance transcription elongation 
efficiency1,2,4,5. Capped analysis of gene expression (CAGE) experiments also indicate that 
transcription commonly initiates within and between genes11–15. To investigate the role of 
intragenic methylation, we generated a map of DNA methylation from human brain encompassing 
24.7 million of the 28 million CpG sites. From the dense, high-resolution coverage of CpG 
islands, the majority of methylated CpG islands were revealed to be in intragenic and intergenic 
regions, while less than 3% of CpG islands in 5′ promoters were methylated. The CpG islands in 
all three locations overlapped with RNA markers of transcription initiation, and unmethylated 
CpG islands also overlapped significantly with trimethylation of H3K4, a histone modification 
enriched at promoters16. The general and CpG-island-specific patterns of methylation are 
conserved in mouse tissues. An in-depth investigation of the human SHANK3 locus17,18 and its 
mouse homologue demonstrated that this tissue-specific DNA methylation regulates intragenic 
promoter activity in vitro and in vivo. These methylation-regulated, alternative transcripts are 
expressed in a tissue and cell type-specific manner, and are expressed differentially within a single 
cell type from distinct brain regions. These results support a major role for intragenic methylation 
in regulating cell context-specific alternative promoters in gene bodies.
Keywords
Intragenic DNA methylation; alternate promoters; comparative epigenomics; SHANK3
To determine if intragenic DNA methylation is functional, we first generated high-resolution 
methylome maps of human brain frontal cortex gray matter from two individuals. We 
developed two complementary next-generation sequencing-based approaches to detect 
methylated and unmethylated DNA. The first, methylated DNA immunoprecipitation and 
sequencing (MeDIP-seq), uses antibody-based immunoprecipitation of 5-methylcytosine 
and sequencing to map the methylated fraction of the genome. In the second method, 
unmethylated CpG sites are identified at single CpG site resolution by sequencing size-
selected fragments from parallel DNA digestions with the methyl-sensitive restriction 
enzymes (MREs) HpaII, Hin6I, and AciI (MRE-seq, Supplementary Fig. S1).
Of the 28 million CpGs in the haploid human genome, MeDIP-seq covered approximately 
24 million at 100–300bp resolution, while MRE-seq detected approximately 1.7 million 
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unmethylated sites at single CpG site resolution (Supplementary Figs S2–S3). The two 
methods detect different fractions of the genome, with more frequent MeDIP-seq reads 
observed in the commonly methylated CpG-poor fraction (Supplementary Fig. S4). Similar 
results were obtained with frontal cortex from a second individual (Supplemental Figs S5–
S6; Supplemental Excel File 1).
We determined the DNA methylation status of approximately 27,100 of the 27,639 CGIs in 
the human genome from the combined MRE-seq and MeDIP-seq datasets (Supplementary 
Figs S7–S8). MRE-seq scores and MeDIP-seq scores (see Supplemental Methods) for CGIs 
are anti-correlated (Fig. 1a, Pearson correlation = −0.44, p<10−16). An exception is the 
differentially methylated regions (DMRs) of imprinted genes which have significant MRE-
seq and MeDIP-seq signals (Supplementary Fig. S9). In contrast to array-based methods, 
MRE-seq and especially MeDIP-seq can interrogate the methylation status of a large 
fraction of repetitive sequences, which comprise more than 40% of the genome 
(Supplementary Excel File 2). Genome-wide, about 75% of repetitive regions are covered 
by MeDIP reads, compared to 3% for MRE-seq, consistent with high methylation of repeat 
sequences. Validation of MRE-seq and MeDIP-seq by standard bisulfite cloning and 
sequencing of 24 CGI loci (Fig. 1b; Supplementary Fig. S10a–m; Supplemental Excel File 
3) supports the accuracy of MeDIP-seq and MRE-seq for determining methylation status. 
Across gene bodies, including CGIs and non-CGI regions, we found that the average 
methylation level is decreased at the 5′ ends of genes, including ~300 bp downstream of the 
transcription start site (TSS), where methylation might inhibit efficient inititation19, but 
increases in gene bodies as previously reported1,4,20,21 (Supplemental Fig. S11). However, 
gene bodies are often large and may contain multiple discrete regulatory sequences. This 
type of analysis might obscure a more specific role for DNA methylation in regulating 
particular regulatory sequences within gene bodies.
Since CGIs frequently overlap regulatory DNA sequences, our investigation focused on the 
DNA methylation status of intragenic CGIs relative to CGIs from canonical 5′ promoter 
regions, intergenic and 3′ regions. Overall, 16% of all CGIs in the human brain were 
methylated, while 98% of CGIs associated with annotated 5′ promoters were unmethylated 
(Fig. 1c; Supplementary Fig. S12). Notably, 34% of all intragenic CGIs were methylated 
(Fig. 1c). Thus, DNA methylation may serve a broader role in intragenic compared to 5′ 
promoter CGIs in human brain.
We next addressed whether the general pattern of frequent intragenic CGI methylation and 
rare 5′ promoter CGI methylation is evolutionarily conserved. Comparison of our DNA 
methylation profile of human brain with reduced representation bisulfite sequencing-based 
methylation data from mouse brain and 8 additional tissues16, showed the same general 
pattern (Fig. 1c). In addition, tissue-specific methylation, defined here as methylation in at 
least one but not all tissues, is far more common at intragenic CGIs than 5′ promoters (38% 
vs. 2%). The methylation status of intragenic CGIs in human and mouse brain was 
concordant for 80% of the orthologous CGIs (Supplementary table 1). Greater than 99% of 
orthologous 5′ CGIs were unmethylated in human and mouse brain tissue (Supplementary 
table 1). The relative lack of methylation in 5′ promoter CGIs suggests that DNA 
methylation at these sites has only a limited role in regulating tissue-specific transcription 
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initiating from the canonical 5′ promoter region. In contrast, the tissue-specific and highly 
conserved specific pattern of intragenic CGI methylation suggests that it serves a functional 
role for a significant proportion of genes. The pattern of methylation in intragenic CGIs 
cannot be accounted for by presence of transposable elements in the CGIs, as just 1.5% of 
the sequences within these CGIs are annotated as repetitive (Supplementary Excel File 2).
Because many genes have alternative promoters, classically located upstream of the 
translation start site but also commonly present within genes15, we reasoned that a major 
function of the frequent, tissue-specific and conserved intragenic methylation may be to 
regulate the activity of such alternative promoters, as shown in two genes recently5,22. To 
address this hypothesis genome-wide, we determined whether the CGI loci overlap with 
sites of transcription initiation and/or with histone methylation marks typically found in 
association with 5′ promoters.
First, we assessed the relationship between the methylation status of CGIs in human brain 
with CAGE tag datasets from multiple human tissues12,23. CAGE tags are derived from 
mRNA sequenced in the proximity of the 5′-cap site and those tags that map onto unique 
genomic regions correspond to potential transcriptional start sites11–15,24, or in a few cases 
may be derived from posttranscriptionally processed RNAs25. The presence of CAGE tags 
from one or more tissue types suggests the underlying genomic sequence harbors a 
promoter, the activity of which depends on the cellular context and epigenetic status. 
Consistent with this notion, nearly all 5′ promoter CGIs had CAGE tag clusters mapped to 
them from one or more tissues (Fig. 2a), though 98% of them lack DNA methylation in 
human brain. CAGE tags from one or multiple tissues also mapped to intragenic, intergenic 
and 3′ CGIs, a significant proportion of which are methylated in brain tissue. A similar 
relationship between CAGE tag clusters and CGI methylation status was observed in mouse 
tissues (Fig. 2a). Together, these data suggest that sites of tissue-specific intragenic 
methylation overlap with potential alternative CGI promoters embedded within genes, and 
that this relationship is evolutionarily conserved.
To further test the hypothesis that a significant fraction of intragenic CGIs function as 
alternate promoters, we generated a map of trimethylation of histone H3 lysine 4 
(H3K4me3), an epigenetic mark that coincides with promoters, by ChIP-seq on human 
brain. Unmethylated 5′ CGI promoters and H3K4me3 overlapped significantly in human 
brain (Fig. 2b; Supplementary Fig. S13), as observed in mouse16. Interestingly, for 
intragenic CGIs the degree of DNA methylation correlated inversely with the level of 
H3K4me3 signal (Pearson correlation −0.46, p<10−10). The strong overlap of H3K4me3 
with unmethylated intragenic CGIs, the inverse correlation between H3K4me3 signal and 
intragenic CGI DNA methylation, and the presence of CAGE tags from one or more tissues 
suggests that these intragenic sites function as alternative promoters, 34% of which exhibit 
tissue-specific methylation. In data from mouse tissues11,16, we found a strong inverse 
correlation between level of DNA methylation and presence of CAGE tags at intragenic 
CGIs in liver, lung, and brain (Supplementary Fig. S14).
We next performed genome-wide expression profiling using whole-transcriptome shotgun 
sequencing (WTSS), also known as RNA-seq26, on the human frontal cortex sample for 
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which we had generated MeDIP-seq, MRE-seq and H3K4me3 ChIP-seq datasets. The 
cDNA library construction protocol employed enriches for full-length mRNAs and tags their 
5′ ends, and in conjunction with computational detection and clipping of these 5′ tags, 
followed by mapping of the adjacent cDNA sequence, allows the inference of putative TSS 
(Supplemental Methods). Unmethylated, H3K4me3-positive intragenic CGIs were 
associated with putative TSS significantly more often than methylated, H3K4me3-negative 
intragenic CGIs. The relationship between DNA methylation, H3K4me3 and transcription 
initiation sites is further illustrated by a heatmap view of all intragenic CGIs based on five 
independent experiments (Fig. 2c; Supplementary Fig. S15; Supplementary Table 2). Thus, 
our RNA-seq data complement the observations made with CAGE tag datasets, and further 
strengthen the hypothesis that intragenic methylation regulates alternative promoters.
In parallel with the genome-wide analyses, we investigated in-depth a single locus with a 5′ 
promoter CGI, two conserved intragenic CGIs, one conserved 3′CGI, and one additional 
intragenic CGI in humans not present in mice. Our prior analysis of this locus, the autism 
and 22q deletion syndrome gene SHANK317,18, demonstrated evolutionarily conserved and 
tissue-specific intragenic methylation at one CGI7. The 5′ promoter CGI of SHANK3 was 
unmethylated, while one intragenic and one 3′ CGI exhibited methylation and two intragenic 
CGI were predominantly unmethylated (Fig. 3a). Bisulfite sequencing across matched 
tissues from mice and humans revealed strongly conserved patterns of DNA methylation in 
SHANK3 (Supplementary Fig. S16). The 5′ CGI was unmethylated in all tissues analysed in 
both species, irrespective of SHANK3 expression.
We first searched for in vivo evidence of promoters embedded within SHANK3 by 
integrating sequence conservation (ECRs), evidence of transcription initiation in both mouse 
and human tissues (CAGE tags), the presence of H3K4me3 in human brain as well as 
overlapping H3K4me3 and H3K27me3 peaks from ChIP-Seq analyses of ES cells27. Five 
intragenic regions were identified with most or all of these features (Fig. 3a). For two 
intragenic CGIs, we used 5′-RACE to confirm intragenically initiating transcripts in brain, 
but not lung, originating from ECR22 (transcript 22t) and ECR32 (transcript 32t) in mouse 
and human tissue (Fig. 3b and data not shown). Both 22t and 32t are comprised of unique 
first exons and downstream sequences that correspond to the known exons of the full-length 
SHANK3, and contain conserved translational start sites in-frame with the full-length 
SHANK3 protein (Fig. 3b). ECR22 and ECR32 harbor significant promoter activity, which 
is abolished by in vitro methylation (Fig. 3c and Supplementary Fig. S17). In vivo, the DNA 
methylation status of ECR22 and ECR32 promoters is inversely correlated with 22t and 32t 
transcription, respectively, and their expression patterns are similar in matching mouse and 
human tissues (Supplementary Fig. S18). In particular, the tissue-specific DNA methylation 
levels of ECR32 are also cell-type and brain-region specific (Supplementary Figs S18–19), 
and evolutionarily conserved (Fig. 3d). Treatment of primary cortical astrocytes with a DNA 
methylation inhibitor increased transcripts from the normally methylated ECR32 intragenic 
promoter (Fig. 3e), but had no effect on the full-length transcript originating from the 
constitutively unmethylated 5′ promoter CGI (Fig. 3f). Conversely, treatment with a histone 
deacetylase inhibitor activated the full-length transcript significantly with little change to 32t 
expression (Fig. 3f). Combined inhibition of DNA methylation and HDAC activity did not 
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increase 32t beyond the effect of blocking DNA methylation alone (Fig. 3e), nor did it 
increase the full-length transcript expression beyond HDAC inhibition alone (Fig. 3f). 
Interestingly, primary astrocytes derived from the hippocampus exhibited opposite 
methylation and expression levels of ECR32 and 32t relative to cortical astrocytes 
(Supplementary Fig. S19 and Fig. 3e). Additionally, unlike cortical astrocytes, the level of 
32t expression in hippocampal astrocytes remained unchanged after HDAC and DNA 
methylation inhibition (Fig. 3e). In contrast, an increase in expression of the full-length 
SHANK3 was observed in both astrocyte populations following treatment with an HDAC 
inhibitor (Fig. 3f). Thus, in addition to the brain-region specific differences between 
astrocytes, the full-length SHANK3 and 32t appear to be regulated by distinct epigenetic 
mechanisms within the same cells. Similarly, an intragenic CGI in a second gene, Nfix, also 
functions as a methylation-regulated intragenic promoter (Supplemental Fig. S20)
Increased gene body methylation correlates with increased transcription genome-wide1,2,4,5, 
which is seemingly contradictory to our main conclusion. Indeed, in our human brain data, 
moderately expressed genes exhibited greater gene body methylation on average 
(Supplementary Fig. S21). However, these correlations use the average methylation level 
over the entire gene body rather than examining specific CGI sites with potential regulatory 
function, and involve gene expression measurements that do not discriminate which 
transcripts are being measured when multiple overlapping transcripts are present. In 
contrast, the integration of CAGE tags, H3K4me3 peaks and RNA-seq-inferred TSS allow 
precise mapping of genomic sites of transcription initiation and promoter function.
Despite the stereotype, DNA methylation does not appear to play a major role in gene 
regulation from 5′ CGI promoters of most autosomal genes, where histone acetylation and 
histone methylation may be more relevant. Our study also highlights an underappreciated 
complexity of DNA methylation-associated regulation of alternative promoters within gene 
bodies, including differences in this regulation within a single cell type from distinct brain 
regions, and in different regions of the same gene in the same cell. In light of the precision 
afforded by our approach and the new conclusions drawn from it, it may now be possible to 
reconcile prior controversies on the role of DNA methylation in the regulation of gene 
expression during development and cancer28,29. The role of intragenic DNA methylation is 
but one of many possible important new advances afforded by the synthesis of integrative 
epigenomics and comparative genomics.
Online-Only Methods
DNA isolation
Cells were lysed in DNA extraction buffer (50 mM Tris pH 8.0, 0.5% sodium dodecyl 
sulfate, 0.5 mM EDTA pH 8.0, and 1 mg/ml proteinase K) overnight at 55° C. RNA was 
removed with RNase treatment (40 μg/ml, Roche DNase-free RNase) for 1 hr at 37° C. 
DNA was purified with 2 phenol/chloroform/isoamyl alcohol extractions followed by 2 
chloroform extractions using phase lock gels. DNA was precipitated with sodium acetate 
and ethanol, washed with 70% ethanol, and resuspended in TE buffer.
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MRE-seq
Three parallel digests were performed (HpaII, AciI, and Hin6I; Fermentas), each with 1–5 
μg of DNA. Five units of enzyme per microgram DNA were added and incubated at 37° C 
in Fermentas “Tango” buffer for 3 hrs. A second dose of enzyme was added (5 units of 
enzyme per microgram DNA) and the DNA was incubated for an additional 3 hrs. Digested 
DNA was precipitated with sodium acetate and ethanol, and 500 ng of each digest were 
combined into one tube. Combined DNA was size-selected by electrophoresis on a 1% 
agarose TBE gel. A 100 – 300 bp gel slice was excised using a sterile scalpel and gel-
purified using Qiagen Qiaquick columns, eluting in 30 μl of Qiagen EB buffer. Library 
construction was performed using the Illumina Genomic DNA Sample Kit (Illumina Inc., 
USA) with single end adapters, following the manufacturer’s instructions with the following 
changes. For the end repair reaction, T4 DNA polymerase and T4 polynucleotide kinase 
were excluded and the klenow DNA polymerase was diluted 1:5 in water and 1 μl used per 
reaction. For single end oligo adapter ligation, adapters were diluted 1:10 in water and 1 μl 
used per reaction. After the second size selection, DNA was eluted in 36 μl EB buffer using 
Qiagen Qiaquick columns, and 13 μl used as template for PCR, using Illumina reagents and 
cycling conditions with 18 cycles. After cleanup with Qiagen MinElute columns, each 
library is examined by spectrophotometry (Nanodrop, Thermo Scientific, USA) and Agilent 
DNA Bioanalyzer (Agilent, USA).
MeDIP-seq
For MeDIP, 5–15 μg DNA isolated as described above was sonicated to ~100–500 bp with a 
Bioruptor sonicator (Diagenode). Sonicated DNA was end-repaired, A-tailed, and ligated to 
single-end adapters following the standard Illumina protocol. After agarose size-selection to 
remove unligated adapters, 2–5 μg of adapter-ligated DNA was used for each 
immunoprecipitation using a mouse monoclonal anti-methylcytidine antibody (1 mg/ml, 
Eurogentec, catalog # BI-MECY-0100). For this, DNA was heat denatured at 95° C for 10 
minutes, rapidly cooled on ice, and immunoprecipitated with 1 μl primary antibody per 
microgram of DNA overnight at 4° C with rocking agitation in 500 μl IP buffer (10 mM 
sodium phosphate buffer, pH 7.0, 140 mM NaCl, 0.05% Triton X-100). To recover the 
immunoabsorbed DNA fragments, 4 μl of rabbit anti-mouse IgG secondary antibody (2.5 
mg/ml, Jackson Immunoresearch) and 100 μl Protein A/G beads (Pierce Biotechnology) 
were added and incubated for an additional 2 hr at 4° C with agitation. After 
immunoprecipitation a total of 6 IP washes were performed with ice cold IP buffer. A 
nonspecific mouse IgG IP (Jackson Immunoresearch) was performed in parallel to methyl 
DNA IP as a negative control. Washed beads were resuspended in TE with 0.25% SDS and 
0.25 mg/ml proteinase K for 2 hrs at 55° C and then allowed to cool to room temperature. 
MeDIP and supernatant DNA were purified using Qiagen MinElute columns and eluted in 
16 μl EB (Qiagen, USA). Fifteen cycles of PCR were performed on 5 μl of the 
immunoprecipitated DNA using the single end Illumina PCR primers. The resulting 
reactions are purified over Qiagen MinElute columns, after which a final size selection 
(192–392 bp) was performed by electrophoresis in 2% agarose. Libraries were QC’d by 
spectrophotometry and Agilent DNA Bioanalyzer analysis. An aliquot of each library was 
diluted in EB to 5 ng/μl and 1 μl used as template in 4 independent PCR reactions to confirm 
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enrichment for methylated and de-enrichment for unmethylated sequences, compared to 5 
ng of input (sonicated DNA). Two positive controls (SNRPN and MAGEA1 promoters) and 
2 negative controls (a CpG-less sequence on Chr15 and GAPDH promoter) were amplified 
(see Supplementary Materials for primer sequences). Cycling was 95° C for 30 s, 58° C for 
30 s, 72° C for 30 s with 30 cycles. PCR products were visualized by 1.8% agarose gel 
electrophoresis.
ChIP-seq of H3K4me3
Human left hemisphere frontal cortex (Brodmann Area 10) was obtained from the Québec 
Suicide Brain Bank (QSBB, Montreal, Québec; http://www.douglasrecherche.qc.ca/brain-
banks/suicide-bank.asp). All tissue was collected with written informed consent from next of 
kin. Experimentation with human brain tissue at the Genome Sciences Centre was carried 
out with approval from the University of British Columbia - British Columbia Cancer 
Agency Research Ethics Board (REB# H07-01589). For immunoprecipitation of H3K4me3-
modified chromatin, human frontal cortex tissue (200–500mg each) from a 57 year old male 
suspended in chilled douncing buffer (250 μl; 10mM Tris-Cl pH7.5, 4mM MgCl2, 1mM 
CaCl2), and homogenized by repeated pipetting followed by passing through a 1 ml 26 
gauge-syringe 6 times. The homogenate was then incubated with 5U/ml of micrococcal 
nuclease (Sigma, USA) for 7 min at 37°C (~90% was mononucleosomes after digestion). 
The reaction was terminated by addition of EDTA (10mM; ~5 μl). To this, 1 ml hypotonic 
lysis buffer (0.2mM EDTA (pH8.0), 0.1mM benzamidine, 0.1mM PMSF, 1.5mM DTT) 
with protease inhibitor cocktail was added. The homogenate was incubated on ice for 60 
min, with brief vortexing at 10 min intervals. The homogenate was centrifuged at 3000g for 
5 min, and the supernatant was transferred to a 1.5 ml non-stick tube. The micrococcal 
nuclease-digested chromatin fraction was pre-cleared with 100 μl of blocked Protein A/G 
sepharose beads (Amersham, USA) at 4°C for 2 hrs, and following centrifugation and the 
supernatant was transferred to fresh tubes. Chromatin immunoprecipitation was carried out 
either with anti-histone H3 trimethyl K4 (H3K4me3) antibody (ab8580, Abcam), or normal 
rabbit IgG antibody (12–370, Upstate Biotechnology) to assess fold enrichment. Antibodies 
were added in manufacturer recommended amounts, and the mixtures incubated at 4°C for 1 
hr. To each reaction mixture, 20 μl of Protein A/G beads were added and incubated by 
rotating at 4°C overnight. Beads were recovered by centrifugation and washed twice with 
ChIP wash buffer (20 mM Tris-HCl [pH 8.0], 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 
150 mM NaCl) and once with ChIP final wash buffer (20 mM Tris-HCl [pH 8.0], 0.1% 
SDS, 1% Triton X-100, 2 mM EDTA, 500 mM NaCl). DNA-antibody complexes were 
eluted using 100 μl elution buffer (100 mM NaHCO3, 1% SDS), and incubated with 5 μg of 
DNAse-free RNAse (Roche, Canada) at 68°C for 2 hrs. The beads were pelleted by 
centrifugation and the supernatant was collected. Elution was repeated with addition of 100 
μl of elution buffer and incubation at 68°C for 5 min. After pooling the two eluates, DNA 
was recovered using the QIAquick PCR Purification kit (Qiagen, Germany). A ChIP-seq 
library were constructed as previously described using 11–35 ng of immunoprecipitated 
DNA.
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Categorization of CpG islands
We obtained genomic locations of CpG islands from the UCSC Genome Browser for human 
(hg18, 27639 islands) and mouse (mm8, 15948 islands). We obtained RefSeq gene 
definition from the UCSC Genome Browser for human (hg18, 29996 genes) and mouse 
(mm8, 22307 genes). We grouped CpG islands into four classes based on their distance to 
RefSeq genes. They are:
1. promoter islands (if an island ends after 1000bp upstream of a RefGene 
transcription start site, and starts before 300bp downstream of a RefGene 
transcription start site);
2. intragenic islands (if an island starts after 300bp downstream of a RefGene 
transcription start site and ends before 300bp upstream of a RefGene transcription 
end site);
3. 3′ transcript islands (if an island ends after 300bp upstream of a RefGene 
transcription end site and starts before 300bp downstream of a RefGene 
transcription end site);
4. intergenic islands (if an island starts after 300bp downstream of a RefGene 
transcription end site and ends before 1000bp upstream of a RefGene transcription 
start site.
See Supplemental Fig. S12 for number of different classes of CpG islands in the human and 
mouse genome.
Definition of Islands with no CpG
We identified 94,239 CpG free regions in the human genome assembly (hg18) that span 
between 1kb to 3kb. We defined the middle 600bp of these regions to be islands with no 
CpG.
DNA methylation score for the mouse
We obtained reduced representation bisulfite sequencing data from Meissner et al. 2008. We 
included data on the following cell types in this analysis: Astro_primary_p2, B cell, Brain, 
ES cell, Liver, Lung, Spleen, T cell CD4, and T cell CD8. Methylation score for individual 
CpG site is defined as number of CG/(CG+TG) from bisulfite sequencing reads. A CpG site 
will have a defined methylation score only when CG+TG is equal or greater than 5; 
otherwise, the score is undefined. Methylation score for individual CpG island is defined as 
the average score of all CpG sites with a defined methylation score within this island. The 
score is multiplied by 1000.
A CpG island is defined as completely methylated if its methylation score is equal or greater 
than 500; as partially methylated if its methylation score is between 100 and 500; and as 
unmethylated if its methylation score is less than 100.
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MeDIP-seq and methylation score for the human
We sequenced the same sample on Illumina GAI and GAII with a total number of reads 
about 106 million. Redundant reads were removed, and 47 million reads were mapped to the 
current human genome assembly (hg18) with MAQ. We extended each mapped reads to 
200bp in length. Overall, 24 million CpG sites are covered by at least one extended read. We 
define a methylation score for any region in the genome as number of extended reads per kb. 
A CpG island is defined as unmethylated if its methylation score is less than 20 reads/kb, as 
partially methylated if its methylation score is between 20 and 50 reads/kb, and as 
completely methylated if its methylation score is greater than 50 reads/kb. See 
Supplementary Fig. S3 for distribution of MeDIP-score across CpG sites and Fig S8 for 
MeDIP-score across CpG islands.
MRE-seq and MRE-score for the human
We sequenced the same sample with Illumina GAI and GAII with a total number of reads 
about 20 million. We mapped these reads to the human genome assembly (hg18) with MAQ 
with an additional constraint that the 5′ end of a read must map to the CpG site within a 
MRE site. This resulted in about 11 million mapped MRE-reads. About 1.5 million CpG 
sites have at least one mapped MRE-read. We define MRE-score for each CpG site as the 
number of MRE-reads that map to the site, regardless of the orientation. We define MRE-
score for each CpG island as the average MRE-score for all CpG sites that have a score 
within the island. See Supplementary Fig. S2 for a distribution of MRE-score across CpG 
sites and Fig S7 for MRE-score across CpG islands.
NIC (Normalized Internal Coverage) score
For any genome-wide data presented in wiggle format, NIC for any given region is defined 
as the total area of the data profile within the region normalized by the length of the region. 
See Supplementary Fig. S13 for distribution of NIC scores of CpG islands with respect to 
H3K4me3.
CAGE association
We used published CAGE data from mouse and human. Tissue-specific CAGE data is 
available as “wiggle” tracks. For each CpG island, we extend the island boundary by 200bp 
in both upstream and downstream directions. If the extended island overlaps with any 
wiggle signal from the CAGE dataset, we calculate NIC score for the island.
Identifying conserved CpG islands between human and mouse
We first syntenically mapped all human CpG islands to the mouse genome assembly (mm8) 
and filtered out those that don’t map. We further filtered out ones that when mapped to the 
mouse, they do not overlap annotated CpG islands. Next, we compared classification of 
these islands (promoter, intragenic, 3′ of transcript or intergenic) and filtered out those pairs 
whose classifications do not match. This results in 2400 pairs of conserved CpG islands 
between human and mouse, 500 of which are intragenic.
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RNA-seq; Identification of putative transcription start sites; Gene expression 
measurements
100 ng of total RNA was used to synthesize full-length single-stranded cDNAs using the 
SMART PCR cDNA Synthesis Kit (Clontech, Mountain View, CA, USA) following the 
protocol as described by Morin et al. The resulting double-stranded cDNAs was assessed 
using an Agilent DNA 1000 series II assay (Agilent, Mississauga ON, Canada) and 
Nanodrop 7500 spectrophotometer (Nanodrop, Wilmington, DE, USA). Sonication was 
performed for a total of 50 minutes using Bioruptor UCD-200 (Diagenode Inc. Sparta, NJ, 
USA). The sheared cDNA was size separated by 8% PAGE and the 200–250bp DNA 
fraction excised and eluted from the gel slice overnight at 4 °C in 300 μl of elution buffer 
(5:1, LoTE buffer (3 mM Tris-HCl, pH 7.5, 0.2 mM EDTA)-7.5 M ammonium acetate), and 
purified using a QIAquick purification kit (Qiagen, Mississauga, ON, Canada). The library 
was constructed following the Illumina genomic DNA paired end library protocol with 10 
cycles of PCR (Illumina Inc., Hayward CA, USA). The resulting PCR product was purified 
using 8% PAGE to remove small products including adapter dimers, and the DNA quality 
was assessed using an Agilent DNA 1000 series II assay and quantified by Qubit 
fluorometer (Invitrogen, Burlington, ON, Canada) and then diluted to 10nM. The final 
concentration was double checked and determined by Quant-iT dsDNA HS Assay Kit using 
Qubit fluorometer (Invitrogen). Cluster generation and paired-end sequencing was 
performed on the Illumina cluster station and Genome Analyzer following manufacturer’s 
instructions (Illumina Inc., Hayward CA, USA).
In total, 93 million paired-end reads (186 million reads) were generated for the frontal cortex 
WTSS-lite library. Custom scripts were used to identify 56.4 million reads that contained the 
SMART oligo sequence and a variable G stretch (added by the RT terminal transferase 
activity) on the 5′ end. Putative TSS were found by identifying WTSS reads containing 
sequence corresponding to SMART oligo tags, clipping these tags informatically, and 
aligning the resulting sequence tag (representing the 5′ end of a full-length mRNA) using 
Maq. In detail: paired end reads were split into forward (read1) and reverse (read2) reads. 
Read 1s were parsed for those which contained reads starting with the SMART tag followed 
by a variable number of Gs and clipped after the terminal G. These variable length sequence 
strings were written to the SMART file (56.4 million reads). All Read2s and those Read1s 
that did not contain the SMART sequence tag were written to a NOSMART file (129.6 
million reads). The SMART file was split into 14 subfiles based on read length and Maq 
(0.7.1) alignments were run and the resulting .map files merged. The NOSMART file was 
split into 2 subfiles (for the 75 and 50bp read lengths), and Maq aligned and the 
resulting .map files merged. The .map files were used to generate SMART and NOSMART 
wig tracks using FindPeaks 2 (xset5; no threshold). For gene expression analysis, the clipped 
and non-clipped reads were pooled (SMART and NOSMART .map files merged), and read 
counts generated at the exon and gene level using custom scripts.
To assess promoter activities of individual CpG islands, we first extended each island 
boundary by 200bp in both upstream and downstream directions and looked for evidence of 
TSS based on RNA-seq data in these regions. We tallied number of SMART and 
NOSMART RNA-seq reads overlapping with each island, and defined TSS activity as (1) 
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having at least 5 SMART tagged reads, and (2) at least 70% of total RNA-seq reads are 
SMART tagged reads.
Normal tissues and cultured primary cells
For the SHANK3 experiments normal human brain samples were provided from the 
Neurosurgery Tissue Bank at the University of California San Francisco (UCSF) and we 
collected adult peripheral blood lymphocytes (PBL) from healthy volunteers. All samples 
were obtained with informed consent, and their use was approved by the Committee on 
Human Research at UCSF. Normal human primary adult keratinocytes and normal human 
fetal astrocytes were purchased from Cambrex and were cultured for fewer than three 
passages. Normal human ES cells (HSF6) were kindly provided by Mary Firpo while at 
UCSF. Mouse whole brain, cerebella, hippocampi, lung, pancreas, heart, PBL, and sperm 
were isolated from normal 8-week old C57BL/6J mice. Keratinocytes from the skin of 
normal newborn NIH/Ola pups were isolated by physical separation of the epidermal layer 
from whole skin. In addition to adult stages, brain and lung tissues were derived from mice 
at pre- and post-natal developmental time points where indicated in the text. Astrocyte 
monolayers were derived from the postmortem cerebral cortex and hippocampus of 
postnatal day 7 C57BL/6J mice. The cerebral cortex dissection was preformed in such a way 
as to exclude all cells of the ventricular or subependymal region. Primary cultures were 
generated by mincing the tissue and incubating it with papain enzyme, after which cells 
were filtered through a 70 μm cell strainer. The resulting cell suspensions were seeded on 
laminin coated plates in DMEM/F12 medium containing 10% (vol/vol) FCS supplemented 
with 2 mM glutamine and allowed to grow to confluence. The cells were confirmed to be 
astrocytes based on morphology and expression of the astrocyte-specific glial fibrillary 
acidic protein. Mouse ES cells (from C57BL/6J blastocysts) were kindly provided by 
Miguel Ramalho-Santos (UCSF). All tissue samples were homogenized for isolation of 
nucleic acids. All cultured cells were collected by trypsinization using 0.25% trypsin-EDTA 
and washed before cell lysis.
Demethylation and deacetylation experiments
Primary mouse astrocytes were seeded at 1 × 105 cells per well of a six-well plate, incubated 
for 24 hours in Dulbecco’s Modified Eagle’s Medium (DMEM) high glucose with 10% 
serum, and then supplemented with fresh media containing 5-aza-2′-deoxycytidine (5azadC) 
(1 or 5 μM; Sigma-Aldrich) for 72 hours or trichostatin A (TSA) (100 ng/ml; Sigma-
Aldrich) for 12 hours. For the combination treatment, 1 or 5 μM 5azadC was present for 72 
hours and TSA was added for the last 12 hours. The media containing drugs were changed 
every 24 hours.
Bisulfite treatment, PCR and sequencing
We treated total genomic DNA with sodium bisulfite for 16 hours and carried out PCR using 
primers listed in Supplementary Table 2, and cloned products into pCR2.1/TOPO 
(Invitrogen). We selected a specified number of individual colonies and sequenced inserts 
using the ABI 3700 automated DNA sequencer. DNA methylation patterns and levels were 
determined only from highly (>95%) converted sequences.
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5′-Rapid amplification of cDNA ends
Total RNA from brain and lung of normal 8-week old C57BL/6J mice were used to amplify 
the 5′ end of SHANK3 mRNA with the Gene Racer kit (Invitrogen) based on the protocol 
supplied by the manufacturer. The mRNA was ligated to the Gene Racer oligo, reverse-
transcribed, and amplified using SHANK3-specific reverse primers R1 or R2 
(Supplementary Table 2) with PfuUltra high-fidelity DNA polymerase (Stratagene) under 
the following 3-step ‘touch-down’ cycling parameters: (1) 5 cycles of 94°C for 30 sec, 72°C 
for 1 min, (2) 5 cycles of 94°C for 30 sec, 70°C for 1 min, (3) 30 cycles of 94°C for 30 sec, 
62°C for 30 sec, and 72°C for 1 min, followed by 72°C for 10 min. The amplification 
products were gel purified, cloned into pCR4-TOPO (Invitrogen), and inserts were 
sequenced. The sequence data for the novel SHANK3 transcripts, 22t and 32t, have been 
deposited into the dbEST database and correspond to accession numbers GD253656 and 
GD253657, respectively. The unique first exon sequences of 22t and 32t correspond to 
chr15:89,354,730–89,355,012 and chr15:89,363,250–89,363,804, respectively (Mouse July 
2007 assembly; http://genome.ucsc.edu). Another transcript with a transcription start site 
downstream of 32t and lacking the full-length SHANK3 exon 18 was also identified by 5′-
RACE (accession number: GD253658).
Reverse transcription, standard and real-time reverse transcription-PCR
Reverse transcription reactions were performed essentially as previously described. From 
mouse samples, we measured the expression of full-length SHANK3 and an internal control 
GusB with probe/primer assays Mm00498775_m1 and Mm00446953_m1 (Applied 
Biosystems), respectively, by real-time RT-PCR using the Opticon2 Continuous 
Fluorescence Detector (MJ Research) and calculated relative expression levels using the 
deltaCt-method. Expression levels of 22t and 32t were measured by RT-PCR using 18S and 
β-actin as internal controls for mouse and human samples, respectively. Primers and their 
corresponding PCR conditions are listed in Supplementary Table 1.
Integration of promoter-associated features at SHANK3
For the SHANK3 locus (chr15:89,328,288–89,388,754; Mouse July 2007 assembly), we 
combined three distinct ‘features’ associated with promoters described in the text. We 
identified ECRs throughout SHANK3 using ‘ECR Browser’: http://ecrbrowser.dcode.org. 
CAGE tag sequences along SHANK3 were obtained from: http://fantom31p.gsc.riken.jp/
cage_analysis. ECRs with 4 or more CAGE tags are shown with arrows in Fig 3a. ChIP-Seq 
data of H3K4me3 and H3K27me3 marks across SHANK3 in ES cells were obtained from: 
http://www.broad.mit.edu/seq_platform/chip. Because all of these features are sequence-
based, we were able to precisely align them in relationship to the corresponding SHANK3 
genomic sequence.
Cloning of ECRs, transfection, and promoter-reporter assays
From mouse or human genomic DNA, selected ECR sequences were PCR amplified with 
PfuUltra high-fidelity DNA polymerase (Stratagene) using primers designed to contain 
specific restriction sites (Supplementary Table 2). We subcloned each PCR product into the 
TOPO-TA cloning vector, selected and sequenced positive colonies, and isolated plasmid 
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DNA containing correct insert sequences. We digested the plasmids, gel-purified the inserts, 
and re-ligated them into a similarly digested pGL3-Basic vector (Promega). We screened for 
and confirmed positive colonies by restriction digestion and sequencing, respectively, and 
isolated plasmid DNA. Using the FuGENE6 reagent (Roche) and according to the 
manufacturer’s instructions, 1 μg of each construct and 10 ng of an internal control vector 
(pRL-hTK; Promega) were co-transfected into HEK-293 cells that were cultured in six-well 
plates containing DMEM media with 10% serum. The pGL3-Basic vector without insert and 
the pGL3 vector containing an SV40 promoter served as negative and positive controls, 
respectively. Firefly luciferase and Renilla luciferase activities were each measured 48 hours 
after transfection by the Dual-Luciferase Reporter Assay System (Promega). As a measure 
of ‘promoter’ strength, luciferase activities were calculated from the intensity of light 
produced as a consequence of beetle luciferin oxidation by Firefly luciferase expressed from 
each ECR construct relative to that of the promoter-less pGL3-basic vector after normalizing 
for transfection efficiency as measured by the intensity of light produced as a consequence 
of coelenterazine oxidation by Renilla luciferase expressed from a co-transfected plasmid. 
Sequences containing promoter activity within ECR5, ECR22, and ECR32 have been 
deposited into the GenBank database and correspond to accession numbers FJ215690, 
FJ215689, FJ215688, respectively.
In vitro DNA methylation assay
Each pGL3-ECR promoter construct was treated with 2 mM S-adenosylmethionine (New 
England Biolabs) in the presence (methylated) or absence (‘mock’-methylated) of 6 units of 
M.SssI (CpG) methylase per μg of DNA for 4 hours at 37°C. Aliquots of purified constructs 
were digested with HpaII to confirm the methylation status (data not shown).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Tissue-specific CpG island methylation is prevalent in gene bodies and rare in 5′ 
promoter regions
a, Inverse correlation between MeDIP-seq and MRE-seq in 5′ promoter, intragenic, 3′ and 
intergenic CGIs. Unmethylated CpGs are shown as an MRE score (a normalized number of 
reads interrogating each CGI, see Supplementary Methods) on the Y-axis. Methylated 
regions are shown as reads/kb from MeDIP-seq on the X-axis. b, Top, MAPK4 with 
methylated regions (MeDIP-seq, dark brown) and unmethylated CpG sites (MRE-seq, 
green). Zoomed-in views of each CGI are shown below, and percent methylation for each 
CpG site assessed by bisulfite sequencing is graphed to the right. c, Percent of CGIs that 
exhibit methylation in a particular tissue, methylation in one or more tissues (mouse16, at 
least one cell type), or tissue-specific methylation (mouse, differentially).
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Figure 2. Differentially methylated intragenic CGIs exhibit features of promoters
a, Methylated CGIs are indicated above the zero line and unmethylated CGIs are below. For 
human, the methylation data is from frontal cortex, and CAGE tags are derived from 
multiple tissues11,23. For mouse, the methylation data includes the same set of tissues 
described in figure 1c, and CAGE data are derived from multiple mouse tissues11,12. 91% of 
human intragenic CGI CAGE tags mapped outside of exons and are probably not derived 
from posttranscriptional processing. b, H3K4me3 tissue-ChIP-seq normalized internal 
coverage (NIC) scores compared to MeDIP- and MRE-seq methylation data at CGIs for 
human frontal cortex. c, Heatmap view of the status of 8092 intragenic CGIs based on five 
genome-wide datasets. Each island is coloured according to its status and sorted from top to 
bottom in the order of increasing signal in MeDIP-seq, then within the three MeDIP-defined 
subgroups by signals in MRE-seq. This process is performed iteratively based on H3K4me3, 
RNA-seq TSS and CAGE status. For MeDIP-seq, green indicates unmethylated (0–20 reads/
kb), maroon indicates partially methylated (20–50 reads/kb), and red indicates methylated 
(>50 reads/kb); For MRE-seq, green indicates unmethylated (MRE score 0–5), red indicates 
methylated (MRE score >5); For H3K4me3 ChIP-seq, green indicates active/with signal, red 
indicates inactive/without signal. For RNA-seq TSS, green indicates evidence for TSS, red 
indicates lack of evidence for TSS (see Supplemental Methods). For CAGE, green indicates 
CAGE tags from one or more tissues that overlap the CGI; red indicates lack of overlapping 
CAGE tags.
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Figure 3. Novel transcripts initiate from differentially methylated, evolutionarily conserved 
intragenic promoters in a cell context-dependent manner
a, Human frontal cortex MRE-seq, MeDIP-seq and H3K4me3 ChIP-seq at SHANK3 (top). 
Evolutionarily conserved regions (ECRs) overlap with mouse CAGE tag clusters (arrows), 
mouse ES H3K4me3 and H3K27me3 bivalent domains27 and human frontal cortex 
H3K4me3. ECRs with most or all promoter-associated features are shown with light grey 
bars. b, Diagram of ECR22 (left) and ECR32 (right) mouse genomic regions displaying 
from top to bottom ECRs, sequences used for promoter assays, 5′ RACE sequences of 22t 
and 32t with associated ATGs (arrow), known exons, CpG island (dark green) and CpG-rich 
(light green) regions, and multi-species DNA sequence conservation. c, In vitro methylation 
of the mouse SHANK3 intragenic promoters abolished their activity in promoter assays. Me, 
methylated; Mock, mock treated; Un, untreated. d, Bisulfite sequencing of ECR32 in 
matched tissues/cells from human and mouse. P=0.018; ANOVA regression analysis. e, 
Increased 32t transcription in cortical, but not hippocampal astrocytes after treatment with 
5azadC by transcript-specific RT-PCR (p<0.05, Student’s t-test). Positive controls: untreated 
primary cultures of cerebellar granule neural progenitor cells (CGNPs), their in vitro 
differentiated neurons (CG neurons), and whole brain. The 24-bp size difference in CGNPs 
and CG neurons is due to alternative splicing within the 32t transcript. Hi., hippocampal; 
Ctx., cortical. f, Increased expression of full-length SHANK3 detected by qRT-PCR in 
astrocytes treated with TSA alone or in combination with 5azadC (p<0.05, Student’s t-test) 
but not 5azadC alone.
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